National Lipid Association (NLA) 2024 Fall Clinical Lipid Update

National Lipid Association (NLA) 2024 Fall Clinical Lipid Update is organized by National Lipid Association (NLA) and will be held from Sep 06 - 08, 2024 at Omni Dallas Hotel, Dallas, Texas, United States of America.

Description:
This premier event brings together experts, clinicians, and professionals dedicated to advancing lipid care. Dive into cutting-edge research, engage in insightful discussions, and network with leaders in the field. Secure your spot now for a weekend full of enriching opportunities to deepen your understanding of lipid management.

Foundations of Lipidology Course: Sep 05 - 06, 2024
Overview:
The NLA's Foundations of Lipidology course, formerly Lipid Academy, provides an introductory review of the core curriculum in Clinical Lipidology. This course is designed for any healthcare professional seeking to learn the fundamentals of Lipidology. Experts in Lipidology will lecture on basic concepts and guide participants through interactive learning scenarios that provide the knowledge and tools necessary to work effectively in a lipid practice, and prepare for advanced training.

This course is particularly useful to review core elements of Clinical Lipidology and is appropriate for clinicians from the full spectrum of clinical experience including Physicians, Physician Assistants, Nurse Practitioners, Pharmacist, Exercise Physiologists, and Dietitians who are in any phase of training, or even experienced physicians who are looking to take a deeper dive into Lipidology.

The Foundations of Lipidology is offered as a 2-day course prior to NLA meetings (Clinical Lipid Updates [CLU] and Scientific Sessions).

Course Curriculum:

• Lipids, Lipoproteins and Atherosclerosis
• Landmark Clinical Trials
• Dyslipidemia and Inherited Lipid Abnormalities
• Pharmacologic Therapies
• Therapeutic Lifestyle Changes
• Specific Populations Diagnosis and Therapeutic Considerations
• Overview of Clinical Guidelines in Lipid Management
• Challenging Patient Cases

Learning Objectives:
Upon completion of the educational activity, participants should be able to:

• Explain the pathogenesis of atherosclerosis, including the role of inflammation;
• Describe the functions and sources of cholesterol and triglycerides including the role of lipoproteins in atherosclerosis;
• Review basic principles of statistics in clinical trials;
• Discuss key clinical trials of lipid-altering drug therapies used in cardiovascular disease prevention;
• Appraise clinical trial design and methods in published literature;
• Recognize the role of drug therapy in the management of dyslipidemia;
• Review types of pharmacotherapy with lipid-related impacts;
• Review the mechanism of action, pharmacokinetics, and efficacy of approved drugs for the management of dyslipidemia;
• Council patients on dietary recommendation for lipid management;
• Recognize the importance of lifestyle modification in the reduction of cardiometabolic risk;
• Compose a treatment plan for patients with complex lipid disorders;
• Describe treatment approaches for dyslipidemia in specific populations based on age, gender, ethnicity, and cultural variable;
• Discuss current guidelines for the management and treatment of patients with dyslipidemia;
• Identify primary and secondary causes of dyslipidemia;
• Compose a treatment plan for the management of dyslipidemia in specific populations;
• Compose a treatment plan for reducing risk of CVD in patients with dyslipidemia.

Masters in Lipidology Course: Sep 05 - 06, 2024
Overview:
The NLA’s Masters in Lipidology course has been completely revised for 2024. The new course format is intended to provide advanced training to Lipid Specialists and other health care professionals in the treatment of complex lipid disorders. Through case discussions, practical application in practice and the various treatment opinions from the expert faculty, participants in the course will leave with confidence in their role as a consultative lipid specialist. Faculty and guest panelists will cover a number of complex disorders in each course offering. Topics and faculty may vary by course date and location. Participants in this course will learn how to recognize and diagnose complex lipid disorders. The course will also describe the various treatment options for each disorder, key clinical trial data for pharmacologic therapies, and how to develop treatment plans.

Masters in Lipidology is offered as a 2-day course prior to NLA meetings (Clinical Lipid Updates [CLU] and Scientific Sessions).

Course Curriculum:

• Complex Cases and Consultative Lipidology

Learning Objectives:
At the conclusion of this activity, participants should be able to:

• Recognize lipid disorders including (insert Consultative Case Module topics selected) through case discussions.
• Describe mechanism of action, pharmacokinetics, and efficacy of approved therapies to treat lipid disorders.
• Evaluate data from key clinical trials of lipid-altering drug therapies.
• Diagnose complex lipid disorders.
• Compose a treatment plan for patients with complex lipid disorders.
• Distinguish roles in a team-based approach to care.
• Discuss strategies to improve the knowledge, skills or performance of the healthcare team.

Mastering Triglyceride Science: An In-Depth Master’s Course: Sep 06, 2024
Overview:
Join us for our BRAND NEW! Mastering Triglyceride Science Master’s Course – a 1-day master’s level course designed to address knowledge, competence, and practice gaps in managing hypertriglyceridemia and its associated pathophysiological manifestation and to provide you with improved proficiency on the complexities of severe hypertriglyceridemia, and targets of therapy.

The course will review the latest evidence and research on triglyceride disorders, targets of therapy, and existing and novel triglyceride-lowering therapies. Participants will be expected to improve their severe hypertriglyceridemia knowledge and competence, expand the depth of their understanding of lipid science, and help their patients make informed decisions about lipid therapies to reduce the risk of extreme complications related to severe hypertriglyceridemia.

The Mastering Triglyceride is offered as a one-day course prior to NLA meetings (Clinical Lipid Updates [CLU] and Scientific Sessions).

Learning Objectives:
At the conclusion of this activity, participants should be able to:

• Discuss strategies for the management of patients with lipid disorders.
• Recognize the prevalence of triglyceride-rich remnant lipoproteins in ASCVD.
• Discuss treatment options for hypertriglyceridemia, both for primary and secondary prevention of cardiovascular events in patients with ASCVD.
• Outline appropriate therapy options for high CVD risk patients with elevated triglyceride levels.
• Identify the clinical and genetic attributes, available diagnostic tools, and screening practices to aid the identification of individuals with chylomicronemia syndrome.
• Explain the role of genetic testing in the identification of familial chylomicronemia syndrome (FCS) and multifactorial chylomicronemia (MCM).
• Outline appropriate therapy options for patients with chylomicronemia syndrome and multifactorial chylomicronemia.
• Discuss strategies to improve the knowledge, skills, or performance of the healthcare team